From Self-sufficiency
Jump to: navigation, search
Systematic (IUPAC) name
5-isopropyl 3-methyl 2-cyano-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
ATC code C08CA10 (WHO)
PubChem CID 4494
Chemical data
Formula C19H19N3O6
Molar mass 385.370 g/mol[[Script error: No such module "String".]]
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Nilvadipine is a calcium channel blocker (CCB) for the treatment of hypertension and chronic major cerebral artery occlusion.

Pathohistochemical studies have revealed that the volume of the infarction in the middle cerebral artery occlusion model could be decreased by nilvadipine.

Currently, nilvadipine is tested in clinical trial as a possible treatment for Alzheimer's Disease in Ireland by the Roskamp Institute, Florida, USA and Trinity College, Ireland. [1]


Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />

  1. Roskamp Institute | ROSKAMP NILVADIPINE CLINICAL TRIAL Questions and Answers